DDB1 and oculocerebrocutaneous syndrome: In the present study, our findings unveiled the mechanism whereby CRL4CUL4A/DDB1 E3 ligase regulated mitophagy biogenesis in cisplatin-resistant OCCs, suggesting that CRL4CUL4A/DDB1 may serve as a novel anticancer target in cisplatin-resistant OC.